Nasopharyngitis (Common Cold) Global Clinical Trials Review, H1, 2012

• Publication date: February 2012

Nasopharyngitis (Common Cold) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Nasopharyngitis (Common Cold) Global Clinical Trials Review, H1, 2012" provides data on the Nasopharyngitis (Common Cold) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngitis (Common Cold). It includes an overview of the trial numbers an...

Nasopharyngitis (Common Cold) Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Nasopharyngitis (Common Cold) Global Clinical Trials Review, H1, 2012" provides data on the Nasopharyngitis (Common Cold) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngitis (Common Cold). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasopharyngitis (Common Cold). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Global Drug Discovery And Development Industry

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Nasopharyngitis (Common Cold) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Nasopharyngitis (Common Cold) 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Nasopharyngitis (Common Cold) Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Ranbaxy Laboratories Limited 35
Clinical Trial Overview of Ranbaxy Laboratories Limited 35
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
The Dial Corporation 37
Clinical Trial Overview of The Dial Corporation 37
Dr. Willmar Schwabe GmbH & Co. KG 38
Clinical Trial Overview of Dr. Willmar Schwabe GmbH & Co. KG 38
Synthetic Biologics, Inc. 39
Clinical Trial Overview of Synthetic Biologics, Inc. 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
Johnson & Johnson 41
Clinical Trial Overview of Johnson & Johnson 41
Radix Bioresearch, LLC 42
Clinical Trial Overview of Radix Bioresearch, LLC 42
Xigo Health, LLC 43
Clinical Trial Overview of Xigo Health, LLC 43
Danone Research B.V. 44
Clinical Trial Overview of Danone Research B.V. 44
POM Wonderful, LLC. 45
Clinical Trial Overview of POM Wonderful, LLC. 45
Reckitt Benckiser Pharmaceutical, Inc. 46
Clinical Trial Overview of Reckitt Benckiser Pharmaceutical, Inc. 46
Ache Laboratorios Farmaceuticos S/A 47
Clinical Trial Overview of Ache Laboratorios Farmaceuticos S/A 47
Ajanta Pharma Limited 48
Clinical Trial Overview of Ajanta Pharma Limited 48
Taiko Pharmaceutical Co.,Ltd. 49
Clinical Trial Overview of Taiko Pharmaceutical Co.,Ltd. 49
Procter & Gamble Hygiene & Health Care Limited 50
Clinical Trial Overview of Procter & Gamble Hygiene & Health Care Limited 50
UMC Utrecht 51
Clinical Trial Overview of UMC Utrecht 51
Matrixx Initiatives, Inc. 52
Clinical Trial Overview of Matrixx Initiatives, Inc. 52
Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
University of Wisconsin Madison 53
Clinical Trial Overview of University of Wisconsin Madison 53
Charite University 54
Clinical Trial Overview of Charite University 54
University of Florida 55
Clinical Trial Overview of University of Florida 55
Royal Adelaide Hospital 56
Clinical Trial Overview of Royal Adelaide Hospital 56
Polyene Project , Ltd 57
Clinical Trial Overview of Polyene Project , Ltd 57
Department of Health 58
Clinical Trial Overview of Department of Health 58
Hospital de Clinicas de Porto Alegre 59
Clinical Trial Overview of Hospital de Clinicas de Porto Alegre 59
Texas Heart Institute 60
Clinical Trial Overview of Texas Heart Institute 60
Sir Charles Gairdner Hospital 61
Clinical Trial Overview of Sir Charles Gairdner Hospital 61
Shahrekord University 62
Clinical Trial Overview of Shahrekord University 62
Chonbuk National University 63
Clinical Trial Overview of Chonbuk National University 63
The University of Queensland 64
Clinical Trial Overview of The University of Queensland 64
Cardiff University 65
Clinical Trial Overview of Cardiff University 65
West Penn Allegheny Health System 66
Clinical Trial Overview of West Penn Allegheny Health System 66
Dresden University of Technology 67
Clinical Trial Overview of Dresden University of Technology 67
Kyoto University 68
Clinical Trial Overview of Kyoto University 68
Centers for Disease Control and Prevention 69
Clinical Trial Overview of Centers for Disease Control and Prevention 69
Five Key Clinical Profiles 70
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 93
Contact Us 93
Disclaimer 93
Source 94

List of Tables


Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 12
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, G7 Countries, 2012* 18
Nasopharyngitis (Common Cold) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, E7 Countries, 2012* 20
Nasopharyngitis (Common Cold) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 33
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 34
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ranbaxy Laboratories Limited, 2012* 35
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 36
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Dial Corporation, 2012* 37
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe GmbH & Co. KG, 2012* 38
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Synthetic Biologics, Inc., 2012* 39
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 40
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 41
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radix Bioresearch, LLC, 2012* 42
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Xigo Health, LLC, 2012* 43
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Danone Research B.V., 2012* 44
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by POM Wonderful, LLC., 2012* 45
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Reckitt Benckiser Pharmaceutical, Inc., 2012* 46
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ache Laboratorios Farmaceuticos S/A, 2012* 47
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajanta Pharma Limited, 2012* 48
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiko Pharmaceutical Co.,Ltd., 2012* 49
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Procter & Gamble Hygiene & Health Care Limited, 2012* 50
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2012* 51
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Matrixx Initiatives, Inc., 2012* 52
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2012* 53
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite University, 2012* 54
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012* 55
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Adelaide Hospital, 2012* 56
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Polyene Project , Ltd, 2012* 57
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, 2012* 58
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Clinicas de Porto Alegre, 2012* 59
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Heart Institute, 2012* 60
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sir Charles Gairdner Hospital, 2012* 61
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahrekord University, 2012* 62
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chonbuk National University, 2012* 63
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Queensland, 2012* 64
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2012* 65
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by West Penn Allegheny Health System, 2012* 66
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dresden University of Technology, 2012* 67
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 68
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2012* 69

List of Figures


Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 12
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Nasopharyngitis (Common Cold) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Nasopharyngitis (Common Cold) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Nasopharyngitis (Common Cold) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Nasopharyngitis (Common Cold) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
GlobalData Methodology 92